Literature DB >> 24786445

Systemic implementation strategies to improve hypertension: the Kaiser Permanente Southern California experience.

John J Sim1, Joel Handler2, Steven J Jacobsen3, Michael H Kanter2.   

Abstract

The past decade has seen hypertension improving in the United States where control is approximately 50%. Kaiser Permanente has mirrored and exceeded these national advances in control. Integrated models of care such as Kaiser Permanente and the Veterans Administration health systems have demonstrated the greatest hypertension outcomes. We detail the story of Kaiser Permanente Southern California (KPSC) to illustrate the success that can be achieved with an integrated health system model that uses implementation, dissemination, and performance feedback approaches to chronic disease care. KPSC, with a large ethnically diverse population of more than 3.6 million, has used a stepwise approach to achieve control rates greater than 85% in those recognized with hypertension. This was accomplished through systemic implementations of specific strategies: (1) capturing hypertensive members into a hypertension registry; (2) standardization of blood pressure measurements; (3) drafting and disseminating an internal treatment algorithm that is evidence-based and is advocating of combination therapy; and (4) a multidisciplinary approach using medical assistants, nurses, and pharmacists as key stakeholders. The infrastructure, support, and involvement across all levels of the health system with rapid and continuous performance feedback have been pivotal in ensuring the follow-through and maintenance of these strategies. The KPSC hypertension program is continually evolving in these areas. With these high control rates and established infrastructure, they are positioned to take on different innovations and study models. Such potential projects are drafting strategies on resistant hypertension or addressing the concerns about overtreatment of hypertension.
Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24786445     DOI: 10.1016/j.cjca.2014.01.003

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  44 in total

1.  The Kaiser Permanente Los Angeles Annual Research Week Abstracts.

Authors:  John J Sim; Kristen Ironside; Gary W Chien
Journal:  Perm J       Date:  2019-05-31

2.  Comparative Effectiveness of Implementation Strategies for Blood Pressure Control in Hypertensive Patients: A Systematic Review and Meta-analysis.

Authors:  Katherine T Mills; Katherine M Obst; Wei Shen; Sandra Molina; Hui-Jie Zhang; Hua He; Lisa A Cooper; Jiang He
Journal:  Ann Intern Med       Date:  2017-12-26       Impact factor: 25.391

3.  Implementation of the Chronic Care Model to Reduce Disparities in Hypertension Control: Benefits Take Time.

Authors:  Barbara J Turner; Julie A Parish-Johnson; Yuanyuan Liang; Tracy Jeffers; Shruthi V Arismendez; Ramin Poursani
Journal:  J Gen Intern Med       Date:  2018-06-08       Impact factor: 5.128

4.  Hypertension and Target Organ Damage: Don't Believe Everything You Think!

Authors:  George A Mensah
Journal:  Ethn Dis       Date:  2016-07-21       Impact factor: 1.847

5.  Disparities in early mortality among chronic kidney disease patients who transition to peritoneal dialysis and hemodialysis with and without catheters.

Authors:  John J Sim; Hui Zhou; Jiaxiao Shi; Sally F Shaw; Shayna L Henry; Csaba P Kovesdy; Kamyar Kalantar-Zadeh; Steven J Jacobsen
Journal:  Int Urol Nephrol       Date:  2018-03-12       Impact factor: 2.370

Review 6.  Building on a Legacy of Hypertension Research: Charting Our Future Together.

Authors:  George A Mensah; Zorina S Galis; Lawrence J Fine; Melissa E Garcia; Daniel F Levy; Gary H Gibbons
Journal:  Hypertension       Date:  2016-11-14       Impact factor: 10.190

7.  End-Stage Renal Disease Outcomes among the Kaiser Permanente Southern California Creatinine Safety Program (Creatinine SureNet): Opportunities to Reflect and Improve.

Authors:  John J Sim; Michael Batech; Kim N Danforth; Mark P Rutkowski; Steven J Jacobsen; Michael H Kanter
Journal:  Perm J       Date:  2017

8.  2014 Hypertension Guideline: Recommendation for a Change in Goal Systolic Blood Pressure.

Authors:  Joel Handler
Journal:  Perm J       Date:  2015-06-01

9.  Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.

Authors:  Robert M Carey; David A Calhoun; George L Bakris; Robert D Brook; Stacie L Daugherty; Cheryl R Dennison-Himmelfarb; Brent M Egan; John M Flack; Samuel S Gidding; Eric Judd; Daniel T Lackland; Cheryl L Laffer; Christopher Newton-Cheh; Steven M Smith; Sandra J Taler; Stephen C Textor; Tanya N Turan; William B White
Journal:  Hypertension       Date:  2018-11       Impact factor: 10.190

Review 10.  Research Needs to Improve Hypertension Treatment and Control in African Americans.

Authors:  Paul K Whelton; Paula T Einhorn; Paul Muntner; Lawrence J Appel; William C Cushman; Ana V Diez Roux; Keith C Ferdinand; Mahboob Rahman; Herman A Taylor; Jamy Ard; Donna K Arnett; Barry L Carter; Barry R Davis; Barry I Freedman; Lisa A Cooper; Richard Cooper; Patrice Desvigne-Nickens; Nara Gavini; Alan S Go; David J Hyman; Paul L Kimmel; Karen L Margolis; Edgar R Miller; Katherine T Mills; George A Mensah; Ann M Navar; Gbenga Ogedegbe; Michael K Rakotz; George Thomas; Jonathan N Tobin; Jackson T Wright; Sung Sug Sarah Yoon; Jeffrey A Cutler
Journal:  Hypertension       Date:  2016-09-12       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.